What does Dr. Kris Van De Moortele do?

Dr. Kris Van De Moortele is a specialist medical practice in Jabbeke. Private Limited, started on 22 March 2006.

What is the address of Dr. Kris Van De Moortele?

The registered office of Dr. Kris Van De Moortele is located at Fonteinebeekdreef 1, 8490 Jabbeke.

Is Dr. Kris Van De Moortele still active?

Yes. According to the CBE (31 October 2026) Dr. Kris Van De Moortele is active, legal situation “Normale toestand”, started on 22 March 2006.

Is Dr. Kris Van De Moortele registered on Peppol?

Yes, Dr. Kris Van De Moortele is registered on the Peppol network with ID 0208:0880149492.

What is the enterprise number of Dr. Kris Van De Moortele?

The enterprise number of Dr. Kris Van De Moortele is BE0880149492.

When was Dr. Kris Van De Moortele founded?

Dr. Kris Van De Moortele was founded on 22 March 2006.

Who are the directors of Dr. Kris Van De Moortele?

According to the 2026 annual accounts, the directors of Dr. Kris Van De Moortele are: Kris Van De Moortele.

Is Dr. Kris Van De Moortele a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 March 2006; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did Dr. Kris Van De Moortele make in 2026?

Dr. Kris Van De Moortele posted a profit after taxes of € 323,235 in financial year 2026.

What is the revenue of Dr. Kris Van De Moortele?

As a small company, Dr. Kris Van De Moortele is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 482,353.

Dr. Kris Van De Moortele (Private Limited) - Jabbeke

Dossier Dr. Kris Van De Moortele, printed on 1 November 2026 from databakkes.be/en/0880149492/dr-kris-van-de-moortele. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

Dr. Kris Van De Moortele from Jabbeke, company number BE0880149492, closed financial year 2026 with a result of € 323,235 after tax. For that financial year Dr. Kris Van De Moortele recorded a gross margin of € 482,353 and equity of € 1.1 million. Compared with financial year 2025, the result moved from € 299,911 to € 323,235. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 26, 2026.

What it is worth Healthy

€ 1.1 million

▼ 20% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 323,235

▲ 8% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 428,094

▲ 9% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 589,098 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2026

Vehicles and equipment

€ 11,706

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 83

▼ 99% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 33,519

▲ 1% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 291,871 Gross margin 2023: € 291,871 First fiscal year in the series	€ 376,725 Gross margin 2024: € 376,725 ▲ 29% vs 2023 (€ 291,871) Favourable step	€ 430,899 Gross margin 2025: € 430,899 ▲ 14% vs 2024 (€ 376,725) Favourable step	€ 482,353 Gross margin 2026: € 482,353 ▲ 12% vs 2025 (€ 430,899) Favourable step	▲ 12%
Profit after taxes	€ 203,507 Profit after taxes 2023: € 203,507 First fiscal year in the series	€ 259,014 Profit after taxes 2024: € 259,014 ▲ 27% vs 2023 (€ 203,507) Favourable step	€ 299,911 Profit after taxes 2025: € 299,911 ▲ 16% vs 2024 (€ 259,014) Favourable step	€ 323,235 Profit after taxes 2026: € 323,235 ▲ 8% vs 2025 (€ 299,911) Favourable step	▲ 8%
Equity	€ 1,098,434 Equity 2023: € 1,098,434 First fiscal year in the series	€ 1,188,836 Equity 2024: € 1,188,836 ▲ 8% vs 2023 (€ 1,098,434) Favourable step	€ 1,323,391 Equity 2025: € 1,323,391 ▲ 11% vs 2024 (€ 1,188,836) Favourable step	€ 1,057,528 Equity 2026: € 1,057,528 ▼ 20% vs 2025 (€ 1,323,391) Unfavourable step	▼ 20%
Total debts	€ 45,430 Total debts 2023: € 45,430 First fiscal year in the series	€ 50,701 Total debts 2024: € 50,701 ▲ 12% vs 2023 (€ 45,430) Unfavourable step	€ 47,437 Total debts 2025: € 47,437 ▼ 6% vs 2024 (€ 50,701) Favourable step	€ 543,797 Total debts 2026: € 543,797 ▲ € 496,361 vs 2025 (€ 47,437) Unfavourable step	▲ € 496,361
Cash	€ 267,508 Cash 2023: € 267,508 First fiscal year in the series	€ 506,374 Cash 2024: € 506,374 ▲ 89% vs 2023 (€ 267,508) Favourable step	€ 393,857 Cash 2025: € 393,857 ▼ 22% vs 2024 (€ 506,374) Unfavourable step	€ 428,094 Cash 2026: € 428,094 ▲ 9% vs 2025 (€ 393,857) Favourable step	▲ 9%
Retained profit	€ 1,067,434 Retained profit 2023: € 1,067,434 First fiscal year in the series	€ 1,188,836 Retained profit 2024: € 1,188,836 ▲ 11% vs 2023 (€ 1,067,434) Favourable step	€ 1,323,391 Retained profit 2025: € 1,323,391 ▲ 11% vs 2024 (€ 1,188,836) Favourable step	€ 1,057,528 Retained profit 2026: € 1,057,528 ▼ 20% vs 2025 (€ 1,323,391) Unfavourable step	▼ 20%
Dividend	€ 180,513 Dividend 2023: € 180,513 First fiscal year in the series	€ 137,611 Dividend 2024: € 137,611 ▼ 24% vs 2023 (€ 180,513) Unchanged	€ 165,357 Dividend 2025: € 165,357 ▲ 20% vs 2024 (€ 137,611) Unchanged	€ 589,098 Dividend 2026: € 589,098 ▲ 256% vs 2025 (€ 165,357) Unchanged	▲ 256%
Balance sheet total	€ 1,143,863 Balance sheet total 2023: € 1,143,863 First fiscal year in the series	€ 1,239,538 Balance sheet total 2024: € 1,239,538 ▲ 8% vs 2023 (€ 1,143,863) Unchanged	€ 1,370,828 Balance sheet total 2025: € 1,370,828 ▲ 11% vs 2024 (€ 1,239,538) Unchanged	€ 1,601,325 Balance sheet total 2026: € 1,601,325 ▲ 17% vs 2025 (€ 1,370,828) Unchanged	▲ 17%

Key figures of Dr. Kris Van De Moortele, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Dr. Kris Van De Moortele?

What happened at Dr. Kris Van De Moortele in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 26, 2026 New annual accounts for financial year 2026: profit of € 323,235 (▲ 8% vs 2025). Source: NBB ↗
Mar 22, 2006 Start of the company according to the CBE. KBO

In short

From € 203,507 profit in 2023 to € 323,235 profit in 2026.

Paid € 484,507 in corporate taxes since 2023.

Best year ever: 2026, with € 323,235 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Kris Van De Moortele

Dr. Kris Van De Moortele

RadBrugge 4.9%

Behind Dr. Kris Van De Moortele is Kris Van De Moortele. It owns 4.9% of RadBrugge itself.

Directors

According to the 2026 annual accounts

Kris Van De Moortele

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Fonteinebeekdreef 1

8490 Jabbeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0880.149.492
VAT number: BE 0880.149.492
Registered office: Fonteinebeekdreef 1, 8490 Jabbeke
Names & denominations: Dr. Kris Van De Moortele
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 March 2006
Peppol: Active · Active since 24 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗